The 2018 edition of the UW Biosafety Manual is here! The most significant changes include revisions to information on laboratory access, more information on proper laboratory attire and personal protective equipment (PPE), and a revised description of the occupational health program including the serum banking policy and immunization guidelines. A list of changes is included in the log of changes.
This document lists the exempt experiments that fall under Section III-F of the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules.
This brochure describes Investigator Responsibilities under the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules.
These frequently asked questions (FAQs) are designed to help you complete the BUA application. The below FAQs correspond to the full BUA application. The FAQs also pertain to the Change to BUA application, but the numbering of the referenced questions may differ. See Biological Research Approval for information about the review process.
Human source materials, including human cell lines, blood, tissues and other potentially infectious materials (OPIM) are commonly used biohazards in UW research labs. Potentially infectious human materials can contain bloodborne pathogens (BBP) such as human immunodeficiency virus (HIV) and hepatitis B and C viruses.